Skip to main content
NCBI home page
Poultry Science logoLink to Poultry Science
. 2020 Mar 19;99(6):2926–2930. doi: 10.1016/j.psj.2019.12.069

Research Note: Association of temporal expression of myostatin with hypertrophic muscle growth in different Japanese quail lines

Dong-Hwan Kim ∗, Young Min Choi †, Yeunsu Suh ∗, Sangsu Shin ‡, Joonbum Lee ∗,§, Seongsoo Hwang #, Kichoon Lee ∗,§,1
PMCID: PMC7597642  PMID: 32475426

Abstract

Myostatin (MSTN) negatively regulates in muscle growth and development. Among alternative splicing isoforms of avian MSTN, MSTN-A has antimyogenic activities and MSTN-B functions as a promyogenic factor. In this study, different lines of Japanese quail were used: a random bred control (RBC) and a heavy weight (HW) quail line with muscle hypertrophy. The objectives of the current study are to compare temporal expression of the MSTN isoforms in pectoralis major muscle (PM) between 2 quail lines and to relate MSTN expression with temporal changes in muscle growth and total amounts of DNA in PM. Gains of body weight (BW) and PM weight were greater until posthatch day (D) 28 (P < 0.001), and the fold increases in total DNA contents of PM were greater in the HW line compared with the RBC line during D7 to D28 (P < 0.05). PCR analysis showed that MSTN-A expression was greater at 14 D (E14) of embryonic age (P < 0.01), D7 (P = 0.052), and D14 (P < 0.01) in the RBC line compared with the HW line. At D28 and D75, expression of MSTN-A was greater in the HW line compared with the RBC line (P < 0.05). MSTN-B expression was barely detectable from E14 to D14 and measurable from D28 to D75 in the muscle of both lines. Ratios of the MSTN-B/-A form ranging from 0.15 to 0.29 indicate a minor expression of the B form. Taken together, the lesser expression levels of MSTN-A at E14, D7, and D14 are associated with the fast growth of PM, and greater MSTN-A expression at D28 and D75 are associated with a slowdown of PM growth in the HW line. These data indicate a negative association of MSTN expression with PM growth and provide a scientific basis for potential usage of MSTN expression as a selection marker for greater muscle growth in poultry.

Key words: myostatin, hypertrophy, HW quail, muscle development, MSTN isoforms

Introduction

Myostatin (MSTN) is well-known to have inhibitory effects on muscle growth which were demonstrated by increased fiber size and fiber number in muscles of MSTN knockout (KO) mice (McPherron et al., 1997). The inhibitory role of MSTN in muscle development was further confirmed in cattle, dogs, and humans, which have mutations in the MSTN gene and exhibit a double muscling phenotype (Grobet et al., 1997, Schuelke et al., 2004, Mosher et al., 2007). Recently, knockdown of myostatin expression in chickens by shRNA resulted in a 15% increase in body weight at 6 wk of age (Bhattacharya et al., 2019).

Antimyogenic activities of MSTN can be achieved by processing of promyostatin (pro-MSTN) to mature myostatin. Myostatin is initially formed as a pro-MSTN, which undergoes 3 proteolytic processing events to generate the biologically active mature MSTN (Wolfman et al., 2003, McFarlane et al., 2005). The mature MSTN dimers are capable of binding to the receptors, resulting in generation of antimyogenic signals. Although several approaches successfully inactivated MSTN and increased muscle mass or inhibited muscle wasting, natural mechanisms or endogenous factors that regulate maturation processes of pro-MSTN during muscle development have not been clearly demonstrated.

Avian MSTN has been found in several isoforms by alternative splicing of MSTN mRNA (Shin et al., 2015). In chickens, turkeys, and quail, MSTN-A and MSTN-B isoforms are dominant isoforms in muscle among 5 isoforms (MSTN-A to MSTN-E). Overexpression of the quail MSTN-A form in the quail myogenic cell line (QM7) inhibited myogenic differentiation. The quail MSTN-B form encodes only 129 amino acids by alternative splicing and consequently creating a premature stop codon and consists of only a half of MSTN prodomain (Shin et al., 2015). In the mouse, the MSTN prodomain is known to bind to mature MSTN and to inhibit mature MSTN (Walker et al., 2016). The MSTN prodomain enhanced myogenic differentiation in vitro and also increased muscle mass in transgenic animals with overexpression of the MSTN prodomain (Yang et al., 2001, Lee, 2012). Interestingly, the quail MSTN-B form can enhance myogenic differentiation of QM7 cells by binding to the N-terminal part of the pro-MSTN and inhibiting processing of the pro-MSTN to mature MSTN protein. Therefore, the MSTN-B form in the avian species has been suggested to be a promyogenic factor. However, the temporal expression of MSTN-A and MSTN-B forms in avian muscle tissue has yet to be investigated. In the current study, expression of MSTN-A and MSTN-B forms was compared between a heavy weight (HW) quail line with a hypertrophic muscle growth and a random-bred control line (Choi et al., 2013). In addition, differences in temporal expression of MSTN forms between 2 different genetic quail lines were related to differences in characteristics of muscle growth and maturation.

Materials and methods

Experimental Birds and Animal Usage

All the animal care and experiments were approved by The Ohio State University Institutional Animal Care and Use Committee (protocol no. 2013A00000041). Fertile eggs of random bred control (RBC) and HW quail lines were obtained from the Ohio Agricultural Research and Development Center of The Ohio State University. Quail was sacrificed by CO2 inhalation followed by cervical dislocation as guided by IACUC protocol (protocol no. 2013A00000041). The eggs were incubated with turning through a 90 arc rotation every 2 h. Body weight and Pectoralis major muscle (PM) tissues weight were calculated until 75 D of postnatal, and for RNA extraction, PM tissues were sampled at different developmental stages: embryonic day (E) 14 and postnatal day (D) 1, 7, 14, 28, and 75. At each time point, collected samples were snap-frozen in liquid nitrogen and stored at −80°C until used for analysis. Only male quail was used in this study.

DNA Concentration, RT-PCR, and Quantitative Real-time PCR

For DNA concentration, the whole right PM tissue was used for the analysis according to the method described in a previous study (Choi et al., 2013). Total RNA was isolated using Trizol (Life Technologies Inc.) according to the manufacturer's instructions. Quantity and quality of RNA were assessed by Nanodrop 1000 (Nanodrop Technology). Approximately 1 μg of RNA was reverse-transcribed to cDNA using Moloney murine leukemia virus reverse transcriptase (Invitrogen) with a thermocycler, 65°C for 5 min, 37°C for 52 min, and 70°C for 15 min, and 1 μg of cDNA was used for RT-PCR or quantitative real-time PCR (qPCR). To quantify folds of gene expression, qPCR was performed in a thermocycler, the ABI 7500 (Applied BioSystems) using AmpliTaq Gold polymerase (Applied BioSystems) with the condition, 95°C for 10 min followed by 40 cycles of 94°C for 15 s, 55°C for 45 s, 72°C for 40 s, and 82°C for 32 s with primer sets; MSTN, F: 5′-GGTATCTGGCAGAGTATTGATGTGAA and R: 5′-CAAAATCTCTGCGGGACCGT. For RT-PCR, DNA Taq-polymerase (New England BioLabs) was used. To avoid PCR saturation and get a linear amplification (Oh et al., 2011), PCR products were amplified for 26, 28, 30 cycles for ribosomal protein S13 (Rps13) at denaturing 95°C for 30 s, annealing at 57°C for 30 s, and extension at 72°C for 30 s with specific primer sets; F: 5′-AAGAAGGCTGTTGCTGTTCG and R: 5′-GGCAGAAGCTGTCGATGATT and for 30, 32, 34 cycles for MSTN at denaturing 95°C for 30 s, annealing at 52°C for 30 s, and extension at 72°C for 30 s with specific primer sets: F: 5′-AGCACCTAACATTAGCAGGGACGT and R: 5′-TTCACATCAATACTCTGCCAGATACC. The PCR products were separated by 2% agarose gel electrophoresis and stained by ethidium bromide, and images of PCR products on gels at 26 cycles for Rps13 and 34 cycles for MSTN were captured by a gel imaging system (FOTO/Analyst Express, Fisher Scientific). Rps13 was used as an internal control for qPCR and RT-PCR. The expression levels were normalized to those of endogenous Rps13, and the data were analyzed using the ΔΔCt method (Livak and Schmittgen, 2001). Densitometry analysis of the specific bands was performed using NIH ImageJ software.

Statistical Analysis

All data were expressed as means ± SEM (n ≥ 3). The data were analyzed using Graphpad Prism software, version 6.02. For all comparisons in this study, multiple t-tests were conducted. P-value, P < 0.05, was considered a statistically significant difference.

Results and discussion

The 2 genetic lines of quail used in the current study originated from the same population of quail (Nestor et al., 2002, Nestor et al., 2012). The HW quail were developed at The Ohio State University by selectively breeding for their greater body weight compared with the RBC line for more than 80 generations (Nestor et al., 1983). Our previous studies described characteristics of the HW quail line providing a new avian model for muscle hypertrophy with no significant differences in the total fiber numbers between the RBC and HW lines (Choi et al., 2014a, Choi et al., 2014b). In the current study, visual differences in sizes of bodies and PM between RBC and HW lines were presented in Figures 1A and 1C, and the gains of BW and PM weight were compared between RBC and HW lines (Figures 1B, 1D, and 1E). The rates of body weight gain were greater in the HW line compared with the RBC line. Especially, the body weight gained 11 g in RBC and 43 g in the HW line from D7 to D14 (P < 0.001), and 44 g in RBC and 117 g in the HW line from D14 to D28 (P < 0.001). The rate of PM weight gains also showed similar patterns with body weight: D0 to D7: 0.4 g vs. 1.3 g (P < 0.001), D7 to D14: 0.6 g vs. 3 g (P < 0.001), D14 to D28: 2.5 g vs. 9 g (P < 0.001) (RBC vs. HW). These detailed characteristics of temporal growth provide a muscle developmental model with which MSTN expression can be related, along with expression of myogenic markers.

Figure 1.

Figure 1

Open in a new tab

Comparison of body weight (BW) and pectoralis major muscle (PM) weight. (A and C) Visual differences of body and breast muscle at 42 D posthatch. (B and D) BW and PM weight (PMW) muscle gain. The value was shown by weight gain of body and PM during development, respectively. (E) PMW gain fold. (F) Fold changes of amount of total PM DNA. Multiple t-test was used for statistical analysis by the Graphpad PRISM 6.02 program. Values present means ± SEM (n = 5). Black square: the RBC lines and White square: the HW lines. ∗: P < 0.05, ∗∗: P < 0.01, ∗∗∗: P < 0.001. NS, no significance; RBC, random bred control; HW, heavy weight.

To investigate temporal expression of MSTN, 2 different methods were employed for measuring combined expression of MSTN-A and MSTN-B forms by qPCR and for separately detecting the 2 forms based on size differences (443 vs. 300 bps) by RT-PCR followed by gel electrophoresis and densitometry analysis. The primer sets used for 2 methods were described in Figure 2A and the materials and methods section. Previous studies showed greater embryo weights and expression of a proliferation marker MyoD in the muscle of HW embryos than the RBC at E14 (Berkes and Tapscott, 2005, Choi et al., 2014a), suggesting a more proliferative potential of myoblasts in the HW line. Given the antiproliferative function of MSTN by downregulating MyoD expression in muscle cells (Thomas et al., 2000, Langley et al., 2002), higher MyoD expression and lower MSTN expression in the HW muscle at E14 (P < 0.01) (Figure. 2B) could be related to the greater embryo weight at E14 compared with the RBC line (Choi et al., 2014a).

Figure 2.

Figure 2

Open in a new tab

Comparisons of expression levels of myostatin (MSTN). (A) Schematic diagram shown the loci of specific primer sets for analysis expression levels of MSTN by RT-PCR and qPCR. The primer sets were designated to analyze MSTN-A or MSTN-B form only among isoforms (A–E form). (B) Quantitative analysis of gene expression levels, MSTN-A and MSTN-B form during development by qPCR (n = 4). (C) Gel electrophoresis of MSTN by RT-PCR. The expression of MSTN-A and MSTN-B form in RBC and HW lines at E14, P1, P7, P14, P28, and P75 during development by RT-PCR (n = 3). RPS13 was used as an internal control for qPCR and RT-PCR, both. (D) Densitometry analysis of MSTN or MSTN-A, MSTN-B form. The densitometry analysis was performed using NIH ImageJ software. Multiple t-test was used for statistical analysis by the Graphpad PRISM 6.02 program. Values present means ± SEM. Black square: the RBC lines and White square: the HW lines. ∗: P < 0.05 and ∗∗: P < 0.01. RBC, random bred control; HW, heavy weight.

Right after hatching, chicks before access to food have been under stressful conditions such as the hatching process which demands for high energy expenditure (Lee et al., 2009). The chicks at D0 actively mobilize fatty acid from both adipose tissue and yolk to supply energy for survival (Lee et al., 2009, Chen et al., 2014). This stress condition causes a temporal halt in growth of the chicks that may inhibit expression of MSTN in PM of both RBC and HW lines (Figures 2B and 2C). Similar low expression of MSTN in muscle also has been shown in hatchlings of chickens and ducks (Duan et al., 2016, Dou et al., 2018).

As the HW line was established by selectively breeding for 4-week body weight (Nestor et al., 1983), BW and PMW gains were greater in the HW line during the period of D7 to D28 compared with the RBC line (P < 0.001) (Figure 1). In this period, fold increases in total amounts of DNA in PM were greater in the HW line (P < 0.05) (Figure 1F), suggesting higher rates of cell proliferation in the HW line. Relatively lower expression of MSTN in the HW line than the RBC line at D7 and D14 (P < 0.05) (Figure 2) may allow active cell proliferation and myogenic differentiation, consequently resulting in greater PMW in the HW line.

During the period of D28 to D75, fold increases in PMW gain and total PM DNA were significantly greater in the RBC line than the HW line (Figures 1E and 1F). These data suggest greater cell proliferation per unit of muscle in the RBC line, which is accompanied with a similar gain, but a greater fold change, of PMW (2.9 g of gain from 3.3 g to 6.2 g) in the RBC line from D28 to D75 compared with the HW line (3.5 g of gain from 13.5 g to 17.0 g) (P < 0.01). Relatively greater expression of MSTN may slow down cell proliferation and muscle growth in the HW line; whereas, lower expression of MSTN in the RBC line may activate cell proliferation with accompanied increase in muscle growth at the later stage.

Among 5 MSTN isoforms (A to E forms) in the avian, MSTN-A and MSTN-B form are major and second dominant forms in the muscle, respectively (Huang et al., 2011, Shin et al., 2015). Our previous in vitro study showed that binding of MSTN-B to MSNT-A causes a reduced production of mature MSTN from the MSTN-A, resulting in increases in muscle fiber length, diameter, and nuclei numbers (Shin et al., 2015). In the current study, PCR analysis to detect both forms of MSTN showed absence of MSTN-B expression from E14 to D7, barely detectable levels at D14 and measurable expression levels from D28 to D75 in the muscle of both lines (Figures 2C and 2D). This expression pattern indicates age-associated alternative splicing of MSTN in quail muscle. The greater expression levels of MSTN-A at D28 and D75 are associated with slowdown of PM growth in the HW line (P < 0.05). Ratios of MSTN-B to MSTN-A form ranging from 0.15 to 0.29 indicate minor expression of the B form over A. The role of MSTN-B form in regulation of muscle growth in vivo needs to be further studied by generating transgenic quail overexpressing B form.

Overall, the temporal expression of MSTN is negatively correlated with growth potential of PM muscle in the HW line. Greater rates of breast muscle growth and increasing DNA contents in whole PM of the HW quail are associated with lower MSTN expression from the embryonic age to posthatch day 14. MSTN-B, an alternative mRNA splicing isoform having promyogenic function in vitro, was expressed at very low levels from embryonic age to posthatch day 14 and appeared to be expressed thereafter, suggesting developmental regulation of splicing of MSTN mRNA. Taken together, low expression levels of MSTN in the HW quail line with muscle hypertrophy might function as a selection marker for body weight. The current study shows evidence that expression levels of alternative splicing variants of MSTN is age-related and that expression levels of MSTN-A and MSTN-B might contribute to regulation of muscle growth in quail. These findings provide new insight into use of expression of MSTN variants as a selection marker for a superior line of poultry with high muscle growth and a foundation for future studies focusing on function of MSTN on muscle hypertrophy using gene editing in quail.

Acknowledgments

This work was supported by the Animal Nutrition, Growth and Lactation program area (Program Code: A1231, Project No. 2016-08413) from the USDA National Institute of Food and Agriculture and Animal Science & Technology Development (Project No. PJ01319001) from Rural Development Administration, Republic of Korea.

Conflict of Interest Statement: The authors did not provide any in quail.

References

  1. Berkes C.A., Tapscott S.J. MyoD and the transcriptional control of myogenesis. Semin. Cell Dev. Biol. 2005;16:585–595. doi: 10.1016/j.semcdb.2005.07.006. [DOI] [PubMed] [Google Scholar]
  2. Bhattacharya T.K., Shukla R., Chatterjee R.N., Bhanja S.K. Comparative analysis of silencing expression of myostatin (MSTN) and its two receptors (ACVR2A and ACVR2B) genes affecting growth traits in knock down chicken. Sci. Rep. 2019;9:7789. doi: 10.1038/s41598-019-44217-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chen P., Suh Y., Choi Y.M., Shin S., Lee K. Developmental regulation of adipose tissue growth through hyperplasia and hypertrophy in the embryonic Leghorn and broiler. Poult. Sci. 2014;93:1809–1817. doi: 10.3382/ps.2013-03816. [DOI] [PubMed] [Google Scholar]
  4. Choi Y.M., Sarah D., Shin S., Wick M.P., Kim B.C., Lee K. Comparative growth performance in different Japanese quail lines: the effect of muscle DNA content and fiber morphology. Poult. Sci. 2013;92:1870–1877. doi: 10.3382/ps.2012-02892. [DOI] [PubMed] [Google Scholar]
  5. Choi Y.M., Suh Y., Ahn J., Lee K. Muscle hypertrophy in heavy weight Japanese quail line: delayed muscle maturation and continued muscle growth with prolonged upregulation of myogenic regulatory factors. Poult. Sci. 2014;93:2271–2277. doi: 10.3382/ps.2013-03844. [DOI] [PubMed] [Google Scholar]
  6. Choi Y.M., Suh Y., Shin S., Lee K. Skeletal muscle characterization of Japanese quail line selectively bred for lower body weight as an avian model of delayed muscle growth with hypoplasia. PLoS One. 2014;9:e95932. doi: 10.1371/journal.pone.0095932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dou T., Li Z., Wang K., Liu L., Rong H., Xu Z., Huang Y., Gu D., Chen X., Hu W., Zhang J., Zhao S., Jois M., Li Q., Ge C., te Pas M.F.W., Jia J. Regulation of myostatin expression is associated with growth and muscle development in commercial broiler and DMC muscle. Mol. Biol. Rep. 2018;45:511–522. doi: 10.1007/s11033-018-4187-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Duan X., Ji W., Dong B., Sun G., Bian Y. Myostatin in black Muscovy duck (Cairina moschata): full-length cDNA cloning and age-dependent mRNA expression compared with IGF-I. Br. Poult. Sci. 2016;57:619–627. doi: 10.1080/00071668.2016.1193666. [DOI] [PubMed] [Google Scholar]
  9. Grobet L., Martin L.J.R., Poncelet D., Pirottin D., Brouwers B., Riquet J., Schoeberlein A., Dunner S., Ḿnissier F., Massabanda J., Fries R., Hanset R., Georges M. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat. Genet. 1997;17:71–74. doi: 10.1038/ng0997-71. [DOI] [PubMed] [Google Scholar]
  10. Huang K.L., Wang J.W., Han C.C., Liu H.H., Li L., Dai F., Pan Z., Xu F., He H., Xu H. Developmental expression and alternative splicing of the duck myostatin gene. Comp. Biochem. Physiol. Part D Genomics Proteomics. 2011;6:238–243. doi: 10.1016/j.cbd.2011.04.002. [DOI] [PubMed] [Google Scholar]
  11. Langley B., Thomas M., Bishop A., Sharma M., Gilmour S., Kambadur R. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J. Biol. Chem. 2002;277:49831–49840. doi: 10.1074/jbc.M204291200. [DOI] [PubMed] [Google Scholar]
  12. Lee S.J. Extracellular regulation of myostatin: a Molecular Rheostat for muscle mass. Immunol. Endocr. Metab. Agents Med. Chem. 2012;10:183–194. doi: 10.2174/187152210793663748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lee K., Shin J., Latshaw J.D., Suh Y., Serr J. Cloning of adipose triglyceride lipase complementary deoxyribonucleic acid in poultry and expression of adipose triglyceride lipase during development of adipose in chickens. Poult. Sci. 2009;88:620–630. doi: 10.3382/ps.2008-00265. [DOI] [PubMed] [Google Scholar]
  14. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
  15. McFarlane C., Langley B., Thomas M., Hennebry A., Plummer E., Nicholas G., McMahon C., Sharma M., Kambadur R. Proteolytic processing of myostatin is auto-regulated during myogenesis. Dev. Biol. 2005;283:58–69. doi: 10.1016/j.ydbio.2005.03.039. [DOI] [PubMed] [Google Scholar]
  16. McPherron A.C., Lawler A.M., Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member. Nature. 1997;387:83–90. doi: 10.1038/387083a0. [DOI] [PubMed] [Google Scholar]
  17. Mosher D.S., Quignon P., Bustamante C.D., Sutter N.B., Mellersh C.S., Parker H.G., Ostrander E.A. A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genet. 2007;3:779–786. doi: 10.1371/journal.pgen.0030079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nestor K.E., Bacon W.L., Lambio A.L. Divergent selection for egg production in Coturnix coturnix japonica. Poult. Sci. 1983;62:1548–1552. doi: 10.3382/ps.0621548. [DOI] [PubMed] [Google Scholar]
  19. Nestor K.E., Bacon W.L., Lambio A.L. Divergent selection for body weight and yolk precursor in Coturnix coturnix japonica.: 1. Selection Response. Poult. Sci. 2012;61:12–17. [Google Scholar]
  20. Nestor K.E., Bacon W.L., Velleman S.G., Anderson J.W., Patterson R.A. Effect of selection for increased body weight and increased plasma yolk precursor on developmental stability in Japanese quail. Poult. Sci. 2002;81:160–168. doi: 10.1093/ps/81.2.160. [DOI] [PubMed] [Google Scholar]
  21. Oh S.A., Suh Y., Pang M.G., Lee K. Cloning of avian G(0)/G(1) switch gene 2 genes and developmental and nutritional regulation of G(0)/G(1) switch gene 2 in chicken adipose tissue. J. Anim. Sci. 2011;89:367–375. doi: 10.2527/jas.2010-3339. [DOI] [PubMed] [Google Scholar]
  22. Schuelke M., Hübner C., Riebel T., Kömen W., Wagner K.R., Lee S.-J., Stolz L.E., Tobin J.F., Braun T. Myostatin mutation associated with gross muscle hypertrophy in a child. N. Engl. J. Med. 2004;350:2682–2688. doi: 10.1056/NEJMoa040933. [DOI] [PubMed] [Google Scholar]
  23. Shin S., Song Y., Ahn J., Kim E., Chen P., Yang S., Suh Y., Lee K. A novel mechanism of myostatin regulation by its alternative splicing variant during myogenesis in avian species. Am. J. Physiol. Physiol. 2015;309:C650–C659. doi: 10.1152/ajpcell.00187.2015. [DOI] [PubMed] [Google Scholar]
  24. Thomas M., Langley B., Berry C., Sharma M., Kirk S., Bass J., Kambadur R. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J. Biol. Chem. 2000;275:40235–40243. doi: 10.1074/jbc.M004356200. [DOI] [PubMed] [Google Scholar]
  25. Walker R.G., Poggioli T., Katsimpardi L., Buchanan S.M., Oh J., Wattrus S., Heidecker B., Fong Y.W., Rubin L.L., Ganz P., Thompson T.B., Wagers A.J., Lee R.T. Biochemistry and Biology of GDF11 and myostatin. Circ. Res. 2016;118:1125–1142. doi: 10.1161/CIRCRESAHA.116.308391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wolfman N.M., McPherron A.C., Pappano W.N., Davies M.V., Song K., Tomkinson K.N., Wright J.F., Zhao L., Sebald S.M., Greenspan D.S., Lee S.-J. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc. Natl. Acad. Sci. 2003;100:15842–15846. doi: 10.1073/pnas.2534946100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Yang J., Ratovitski T., Brady J.P., Solomon M.B., Wells K.D., Wall R.J. Expression of myostatin pro domain results in muscular transgenic mice. Mol. Reprod. Dev. 2001;60:351–361. doi: 10.1002/mrd.1097. [DOI] [PubMed] [Google Scholar]

Articles from Poultry Science are provided here courtesy of Elsevier

RESOURCES